Estrogen treatment of patients with established postmenopausal osteoporosis

Obstetrics and Gynecology

Volumn 76, Issue 2, 1990, Pages 290-295

  Lindsay, Robert ^a,b   Tohme, Jack F ^a,b  

^a HELEN HAYES HOSPITAL   (United States)

^b Department of Medicine College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ESTROGEN THERAPY; FEMALE; HUMAN; LIGHT ABSORPTION; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; BONE DENSITY; CALCIUM; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; HUMAN; LUMBAR VERTEBRAE; MIDDLE AGE; OSTEOPOROSIS, POSTMENOPAUSAL; PELVIC BONES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025339574     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;i:1038–41.
2. Lindsay R, Coutts JRT, Hart DM. The effect of endogenous oestrogen on plasma and mineral calcium and phosphate in oophorectomized women. Clin Endocrinol 1977;6:87–93.
3. Christiansen C, Christiansen MS, McNair P. Prevention of early postmenopausal bone loss: Conducted 2-year study in 315 normal females. Eur J Clin Invest 1980;10:273–9.
4. Christiansen C, Rodbro P. Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate. Calcif Tissue Int 1983;35:720–2.
5. Recker RR, Saville PD, Heaney RP. The effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977;87:649–55.
6. Horsman A, Gallagher JC, Simpson M, Nordin BE. Prospective trial of estrogen and calcium in postmenopausal women. Br Med J 1977;2:789–92.
7. Weiss NS, Ure CL, Ballard JH. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1981;303:1195–8.
8. Krieger N, Kelsey JL, Holford TR. An epidemiological study of hip fracture in postmenopausal women. Am J Epidemiol 1982;116:141–8.
9. Ettinger B, Genant HK, Cann CE. Long term estrogen therapy prevents bone loss and fracture. Ann Intern Med 1985;102:319–24.
10. Melsen F, Mosekilde L, Eriksen EF, et al. In vivo hormonal effects on trabecular bone remodeling, osteoid mineralization, and skeletal turnover. In: Kleerekoper M, Krane SM, eds. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert Inc, 1989:73–87.
11. Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, diagnosis, and management. New York: Raven Press, 1988:333–58.
12. Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988;241:81–4.
13. Erikssen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84–6.
14. Albright F. The effect of hormones on osteogenesis in man. Recent Prog Horm Res 1947;1:293–353.
15. Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978;92:953–63.
16. Cannigia A, Gennasi C, Borella G, et al. Intestinal absorption of calcium-47 after treatment with oral estrogen and gestagen in senile osteoporosis. Br Med J 1970;4:30–2.
17. Civitelli R, Agnusdei D, Nardi P, Zacchei F, Avioli LV, Gennari C. Effects of one-year treatment with estrogen on bone mass, intestinal calcium absorption and 25-hydroxyvitamin D-l alpha-hydroxylase reserve in postmenopausal osteoporosis. Calcif Tissue Int 1987;42:77–86.
18. Lindsay R, Fey C, Haboubi A. Dual photon absorptiometric measurements of bone mineral density increase with source life. Calcif Tissue Int 1987;41:293–4.
19. Al-Azzawi F, Hart DM, Lindsay R. Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry. Br Med J 1987;294:1261–2.
20. Munk-Jensen N, Pors-Nielsen S, Obel EB, Bonne-Eriksen P. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study. Br Med J 1988;296:1150–2.
21. Elias C, Heaney RP, Recker RR. Placebo therapy for postmenopausal osteoporosis. Calcif Tissue Int 1985;37:6–13.
22. Melton LJ III. Epidemiology of fractures. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, diagnosis and management. New York: Raven Press, 1988:133–54.
23. Richelson LS, Wahner HW, Melton LJ, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273–5.
24. Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987;156:1516–23.
25. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759–63.